C World Wide Group Holding A Sarepta Therapeutics, Inc. Call Options Transaction History
C World Wide Group Holding A
- $7.38 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
454Shares Held
82.3MCall Options Held
5.6MPut Options Held
4.19M-
Black Rock Inc. New York, NY10.3MShares$238 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$211 Million0.0% of portfolio
-
State Street Corp Boston, MA4.7MShares$108 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$103 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA2.53MShares$58.3 Million0.01% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $2.02B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...